First, the CLCC1‐related ALS patients showed an earlier AAO (48.50 ± 2.87 years, ranging from 40 to 52 years), while our previous work reported a mean AAO of 54.3 ± 10.9 years in sALS patients.33 This evidence concerns the gene CLCC1 and amyotrophic lateral sclerosis.